Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue
/PRNewswire/ -- Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy,...
Stay updated with breaking news from Exablate Neuro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy,...
Expanded indication includes medication-refractory PD patients with motor problems
/PRNewswire/ -- Insightec®, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy,...
Clinical trial data demonstrate that focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.